about
description
clinical trial
@en
name
Study of Infigratinib in Children With Achondroplasia
@en
type
label
Study of Infigratinib in Children With Achondroplasia
@en
prefLabel
Study of Infigratinib in Children With Achondroplasia
@en
P921
P1050
P1476
Phase 2, Open-Label, Dose-Esca ...... With Achondroplasia: PROPEL 2
@en
P3098
NCT04265651
P580
2020-02-01T00:00:00Z
P582
2021-10-01T00:00:00Z